UBS Maintains Neutral on Molina Healthcare, Raises Price Target to $225
Benzinga Newsdesk 1 week ago
Analyst RatingsNewsPrice Target
UBS analyst A.J. Rice maintains Molina Healthcare (NYSE:MOH) with a Neutral and raises the price target from $202 to $225.
UBS analyst A.J. Rice maintains Molina Healthcare (NYSE:MOH) with a Neutral and raises the price target from $202 to $225.